MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • MDS Virtual Congress 2021

    Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias

    I. Walker, S. Shaw, S. Vaishnavi, D. Wolk, N. Dahodwala, J. Morley, J. Duda, A. Chen-Plotkin, A. Siderowf, L. Shaw, E. Lee, J. Trojanowski, M. Grossman, D. Weintraub, D. Irwin (Philadelphia, USA)

    Objective: To investigate the clinical influence of Alzheimer’s disease (AD) co-pathology on motor features in Lewy Body Dementia (LBD). Background: There is considerable heterogeneity of…
  • MDS Virtual Congress 2021

    ASSOCIATION BETWEEN INSULIN RESISTANCE AND DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON´S DISEASE

    C. Borrue-Fernandez, E. Ferriz (San Sebastian Reyes, Spain)

    Objective: The main objective of the study was to analyze the association between insulin resistance (IR ) at  diagnosis and the development of dementia in…
  • MDS Virtual Congress 2021

    Cognitive impairment in patients with Alzheimer’s disease and Parkinson’s disease

    O. Chyniak (Sumy, Ukraine)

    Objective: To compare the results of a neuropsychological study in patients with Alzheimer's disease and Parkinson's disease. Background: Recently, Parkinson's disease (PD) is increasingly considered…
  • MDS Virtual Congress 2021

    Cognitive-driven ADL impairment as a predictor for PDD

    I. Liepelt-Scarfone, M. Bode, K. Brockmann, T. Gasser, K. Michaelis, S. Nussbaum, HC. Nuerk, C. Schulte, W. Maetzler, M. Zimmermann, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To evaluate whether Parkinson’s disease (PD) patients with mild activity of daily living (ADL) impairment are at higher risk for developing dementia (PDD). Background:…
  • MDS Virtual Congress 2021

    Sex-Specific White Matter Correlates of Neuropsychological Measures in Parkinson’s disease with Mild Cognitive Impairment

    V. Mishra, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari, J. Caldwell (Las Vegas, USA)

    Objective: To identify sex-specific white-matter (WM) correlates of neuropsychological measures in Parkinson’s disease (PD) with mild cognitive impairment (MCI). Background: Neuropsychological measures of executive function…
  • MDS Virtual Congress 2021

    The Relationship Between Leptin Levels and Cognitive Status and Disease Stages in Patients with Alzheimer’s Disease

    İ. Tuncer, G. Yuksel, H. Ti̇reli̇ (Kars, Turkey)

    Objective: The aim of this study is to determine the effect of leptin on pathogenesis in patients with Alzheimer type Dementia and Mild Cognitive Impairment…
  • MDS Virtual Congress 2021

    A prospective study of Parkinson’s disease dementia – defining neuropsychological features

    E. Stefanova, LJ. Ziropadja, T. Stojkovic, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To identify neuropsychological predictors of conversion to dementia (PDD) in our cohort of Parkinson’s disease (PD) patients. Background: The heterogeneity of PD cognitive disorders…
  • MDS Virtual Congress 2021

    Differentiation of Mild Cognitive Impairment (MCI) progression to Alzheimer Disease (AD) vs Dementia with Lewy Bodies (DLB): Is this possible neuropsychologically?

    P. Voskou (Athens, Greece)

    Objective: Aim of the present review study was to describe and compare the neurocognitive features of MCI which could predict its progression to DLB vs…
  • MDS Virtual Congress 2021

    A prospective study of Parkinson’s disease progression towards dementia – dynamics and defining motor features

    T. Stojkovic, LJ. Ziropadja, E. Stefanova, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: Our goal was to investigate the rate of progression to dementia (PDD) in our cohort of Parkinson’s disease (PD) patients and to explore how…
  • MDS Virtual Congress 2021

    Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

    R. Patel, G. Stebbins, B. Barton (Chicago, USA)

    Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley